Production (Stage)
HOOKIPA Pharma Inc.
HOOK
$1.53
-$0.03-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 48.01% | -71.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.01% | -71.21% | |||
| Cost of Revenue | 10.37% | -25.15% | |||
| Gross Profit | -5.42% | 5.20% | |||
| SG&A Expenses | 0.28% | 2.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.63% | -16.95% | |||
| Operating Income | -3.36% | 2.44% | |||
| Income Before Tax | 38.43% | -81.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 38.17% | -80.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.17% | -80.26% | |||
| EBIT | -3.36% | 2.44% | |||
| EBITDA | -5.39% | 2.54% | |||
| EPS Basic | 38.19% | -80.25% | |||
| Normalized Basic EPS | 26.36% | -62.30% | |||
| EPS Diluted | 38.18% | -80.25% | |||
| Normalized Diluted EPS | 26.36% | -62.30% | |||
| Average Basic Shares Outstanding | 0.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||